Delcath Systems Announces a Comparative Study of Chemosat and SIRT Published in the Journal CancersPRNewsWire • 10/16/23
Delcath Systems to Participate in the Lytham Partners Fall 2023 Investor ConferencePRNewsWire • 10/10/23
Delcath Systems to Participate at the Roth MKM 2023 Healthcare Opportunities Conference on October 12, 2023PRNewsWire • 10/03/23
A Retrospective Comparative Study of Chemosat and SIRT Presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual MeetingPRNewsWire • 09/11/23
Delcath Systems to Participate at the H.C. Wainwright 25th Annual Investor Conference on September 12 and 13, 2023PRNewsWire • 09/05/23
Delcath Systems, Inc. Announces Additional $35 Million in Funding Tied to the FDA Approval of HEPZATO KIT™PRNewsWire • 09/01/23
Delcath Systems Announces an Independent Investigator Presentation at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual MeetingPRNewsWire • 08/29/23
Delcath Systems, Inc. Announces FDA Approval of HEPZATO KIT™ for the Treatment of Adult Patients with Unresectable Hepatic-Dominant Metastatic Uveal MelanomaPRNewsWire • 08/15/23
Delcath Systems Reports Second Quarter 2023 Results and Provides Business UpdatePRNewsWire • 08/09/23
Delcath Systems to File Its Second Quarter 2023 10-Q the Week of August 7 and Expects to Host a Conference Call the Following WeekPRNewsWire • 08/03/23
Delcath Systems Provides Business Update and Reports Preliminary First Quarter 2023 Financial ResultsPRNewsWire • 05/12/23
Delcath Systems to Participate in the Lytham Partners Spring 2023 Investor ConferencePRNewsWire • 05/09/23
Delcath Systems Announces Resumption of Interest-Only Period for Company's Debt FacilityPRNewsWire • 04/03/23
Delcath Systems Reports Fourth Quarter and Full Year 2022 Results and Provides Business UpdatePRNewsWire • 03/27/23
Delcath Systems, Inc. Announces FDA Acceptance of New Drug Application Resubmission of Hepzato Kit with a PDUFA Date of August 14, 2023PRNewsWire • 03/27/23
Delcath Announces Rotation of the Board of Directors Chairmanship; John R. Sylvester Appointed New Chairman as Company Prepares for US Commercial LaunchPRNewsWire • 02/16/23